Do Hormone Changes during the Ovulation-Menstruation Cycle Increase the Risk of ACL Tears?
Presentation Type
Poster
Faculty Advisor
Fredrick Gardin
Access Type
Event
Start Date
26-4-2024 11:15 AM
End Date
26-4-2024 12:15 PM
Description
Clinical Scenario: It is believed that hormonal changes is one of the etiological factors for female athletes sustaining anterior cruciate ligament injuries. Females are experiencing ACL injuries two to eight times more compared to males. The change in hormone levels during the ovulation-menstruation cycle is believed to increase tissue laxity. Clinical Question: What is the strength of recommendation for strategies to help regulate hormonal level changes? Summary of Key Findings: A critical appraisal of the relevant literature on the relationship between the hormonal levels during the ovulation-menstruation cycle and the change in ligament laxity. The limiters are a relatively small sample size and testing methods. Inclusion criteria included subjects that regularly participated in sport activity at least at the recreational level. Exclusion criteria excluded subjects that have a history of hormonal conditions such as polycystic ovarian syndrome, hysterectomy, unspecified ovarian cyst, and pregnancy. Using SORT for evidence quality score, sources with a score of 2 will be considered. The results indicate a rise in estrogen levels cause a decrease in stiffness of ligaments, increasing the risk of injury. The significant increase in knee laxity measurements occur before ovulation and a decrease in knee laxity occurs after ovulation during the mid-luteal phase. Clinical Bottom Line: Based on the recommendations of the relevant literature, oral contraception can be used to help regulate the hormone levels in female athletes, reducing the risk of increased knee laxity thereby minimizing the risk of ACL injuries. The strength of this recommendation using SORT is grade B.
Do Hormone Changes during the Ovulation-Menstruation Cycle Increase the Risk of ACL Tears?
Clinical Scenario: It is believed that hormonal changes is one of the etiological factors for female athletes sustaining anterior cruciate ligament injuries. Females are experiencing ACL injuries two to eight times more compared to males. The change in hormone levels during the ovulation-menstruation cycle is believed to increase tissue laxity. Clinical Question: What is the strength of recommendation for strategies to help regulate hormonal level changes? Summary of Key Findings: A critical appraisal of the relevant literature on the relationship between the hormonal levels during the ovulation-menstruation cycle and the change in ligament laxity. The limiters are a relatively small sample size and testing methods. Inclusion criteria included subjects that regularly participated in sport activity at least at the recreational level. Exclusion criteria excluded subjects that have a history of hormonal conditions such as polycystic ovarian syndrome, hysterectomy, unspecified ovarian cyst, and pregnancy. Using SORT for evidence quality score, sources with a score of 2 will be considered. The results indicate a rise in estrogen levels cause a decrease in stiffness of ligaments, increasing the risk of injury. The significant increase in knee laxity measurements occur before ovulation and a decrease in knee laxity occurs after ovulation during the mid-luteal phase. Clinical Bottom Line: Based on the recommendations of the relevant literature, oral contraception can be used to help regulate the hormone levels in female athletes, reducing the risk of increased knee laxity thereby minimizing the risk of ACL injuries. The strength of this recommendation using SORT is grade B.